Safety

Evidence Limitations: The current evidence on shilajit's safety profile is extremely limited. The available studies primarily focus on chemical composition, preclinical research, or small clinical trials without dedicated safety assessments. No comprehensive safety data from large-scale human studies are available in the provided evidence.

Known Side Effects

Direct safety data is lacking. None of the provided studies specifically evaluated adverse effects or side effects of shilajit supplementation in humans. The clinical trials listed (NCT02026414, NCT02794454, NCT05573607, NCT06641596, NCT05887050) are completed but their safety outcomes are not detailed in the available evidence.

Contraindications and Special Populations

Evidence is insufficient to establish specific contraindications or identify populations that should avoid shilajit. No studies in the provided evidence address safety in:

• Pregnant or breastfeeding women
• Children and adolescents
• Elderly populations
• Individuals with specific medical conditions
• Those taking medications

Heavy Metal Concerns

One study characterized "metal composition and molecular weight distribution in Shilajit" (PMID: 42364294), suggesting awareness of metal content as a potential safety consideration. However, the actual safety implications of metal content are not detailed in the available evidence.

Drug Interactions

No drug interaction data is available in the provided evidence. While some clinical trials combined shilajit with other compounds (chromium, citrus bioflavonoids, Salacia extract, Phyllanthus emblica), these studies do not provide interaction safety data.

Conservative Recommendations

Given the substantial gaps in safety evidence, individuals should:

• Consult healthcare providers before using shilajit, especially if pregnant, breastfeeding, or taking medications
• Be aware that quality and purity may vary significantly between products
• Monitor for any adverse effects during use

Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Consult your healthcare provider before starting any new supplement, particularly if you have underlying health conditions or take medications.

Research Priority: Comprehensive safety studies evaluating side effects, contraindications, and drug interactions in diverse populations are urgently needed to establish evidence-based safety guidelines for shilajit supplementation.